AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16226510 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 1362
Study 16226510 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 1362
Study 12077736 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomniacs
Number of subjects: 11
Study 12077736 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 11
Study 9848758 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal continuous positive airway pressure (ETCPAP) after rescue surfactant therapy
Number of subjects: 46
Study 7815711 — intervention group
Group type: EXPERIMENTAL
Intervention: Pipecuronium bromide 0.04 mg.kg‐1
Number of subjects: 50
Study 7815711 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium bromide 0.08 mg.kg‐1
Number of subjects: 50
Study 2805024 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride, 0.1 to 0.2 mg/kg three times daily for up to four weeks
Number of subjects: 137
Study 2805024 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study 15357108 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma levels of TNF-alpha and IL-6 in patients with moderate/severe CHF (group 3)
Number of subjects: 118
Study 15357108 — intervention group
Group type: EXPERIMENTAL
Intervention: NYHA functional class (FC)
Number of subjects: 118
Study 15357108 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma TNF-alpha
Number of subjects: 118
Study 15357108 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma IL-6
Number of subjects: 118
Study 15357108 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure
Number of subjects: 118
Study 15357108 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate
Number of subjects: 118
Study 15357108 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular end-diastolic pressure
Number of subjects: 118
Study 30586724 — intervention group
Group type: EXPERIMENTAL
Intervention: BP-SES (biodegradable polymer-based sirolimus-eluting stents)
Number of subjects: 2603
Study 30586724 — intervention group
Group type: EXPERIMENTAL
Intervention: PP-EES (permanent polymer-based everolimus-eluting stents)
Number of subjects: 2603
Study 30586724 — intervention group
Group type: EXPERIMENTAL
Intervention: PP-SES (early generation permanent polymer-based sirolimus-eluting stents)
Number of subjects: 2603
Study 30586724 — intervention group
Group type: EXPERIMENTAL
Intervention: BP-SES
Number of subjects: 2603
Study 30586724 — intervention group
Group type: EXPERIMENTAL
Intervention: PP-EES
Number of subjects: 2603
Study 30586724 — intervention group
Group type: EXPERIMENTAL
Intervention: PP-SES
Number of subjects: 2603
Study 28155569 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtenon drug delivery of demethylvancomycin
Number of subjects: 60
Study 28155569 — intervention group
Group type: COMPARATOR
Intervention: Subconjunctival injection of demethylvancomycin
Number of subjects: 60
Study 26148018 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-casein supplementation for 7 days
Number of subjects: 74
Study 26148018 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 7 days
Number of subjects: 74
Study 22857983 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent androgen deprivation (IAD)
Number of subjects: 852
Study 22857983 — intervention group
Group type: COMPARATOR
Intervention: Continuous androgen deprivation (CAD)
Number of subjects: 852
Study 21595543 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Japanese massage therapy (40‐minute full-body massage)
Number of subjects: 2
Study 21595543 — intervention group
Group type: COMPARATOR
Intervention: Control (40‐minute rest without massage)
Number of subjects: 2
Study 21595543 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Japanese massage therapy
Number of subjects: 2
Study 21595543 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 2
Study 18494201 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative blood salvage system (Group 1)
Number of subjects: 0
Study 18494201 — intervention group
Group type: COMPARATOR
Intervention: Standard suction collection without blood salvage system (Group 2)
Number of subjects: 0
Study 18494201 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative collected autotransfusion blood
Number of subjects: 0
Study 18494201 — intervention group
Group type: COMPARATOR
Intervention: Preoperative collected autologous blood and allogeneic blood
Number of subjects: 0
Study 16569875 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin (NOR)
Number of subjects: 19
Study 16569875 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivmecillinam (PIV)
Number of subjects: 19
Study 12657355 — intervention group
Group type: EXPERIMENTAL
Intervention: Vardenafil 5 mg
Number of subjects: 100
Study 12657355 — intervention group
Group type: EXPERIMENTAL
Intervention: Vardenafil 10 mg
Number of subjects: 100
Study 12657355 — intervention group
Group type: EXPERIMENTAL
Intervention: Vardenafil 20 mg
Number of subjects: 100
Study 12657355 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 10718828 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) treatment
Number of subjects: 15
Study 10718828 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 8937799 — intervention group
Group type: EXPERIMENTAL
Intervention: Heating and peak temperature conditions for full-term infants
Number of subjects: 20
Study 8937799 — intervention group
Group type: EXPERIMENTAL
Intervention: Heating and cooling stages for preterm infants
Number of subjects: 20
Study 1389281 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrifugal pump (Biomedicus)
Number of subjects: 50
Study 1389281 — intervention group
Group type: COMPARATOR
Intervention: Roller pump (Stöckert)
Number of subjects: 50
Study 2988845 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% Butylated hydroxytoluene (BHT) in mineral oil
Number of subjects: 30
Study 2988845 — intervention group
Group type: COMPARATOR
Intervention: Placebo mineral oil vehicle
Number of subjects: 30
Study 29787482 — intervention group
Group type: EXPERIMENTAL
Intervention: High physical activity (PA)
Number of subjects: 913
Study 29787482 — intervention group
Group type: COMPARATOR
Intervention: Premenopausal women
Number of subjects: 913
Study 29787482 — intervention group
Group type: COMPARATOR
Intervention: Postmenopausal women
Number of subjects: 913
Study 27340947 — intervention group
Group type: EXPERIMENTAL
Intervention: External focus instructions on the swing of the club
Number of subjects: 60
Study 27340947 — intervention group
Group type: COMPARATOR
Intervention: Internal focus instructions on the swing of the arm
Number of subjects: 60
Study 25175994 — intervention group
Group type: EXPERIMENTAL
Intervention: High stress condition
Number of subjects: 129
Study 25175994 — intervention group
Group type: COMPARATOR
Intervention: Low stress condition
Number of subjects: 129
Study 22030100 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic sound cue (following the trajectory of an object)
Number of subjects: 100
Study 22030100 — intervention group
Group type: COMPARATOR
Intervention: Static sound cue (sound remained stationary)
Number of subjects: 100
Study 20705788 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (IV dexmedetomidine 2 μg · kg(‐1) over 10 minutes, followed by 0.7 μg · kg(‐1) · h(‐1))
Number of subjects: 122
Study 20705788 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl bolus (IV fentanyl 1 μg · kg(‐1))
Number of subjects: 122
Study 18787524 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased drinking water intake
Number of subjects: 173
Study 15847998 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg piroxicam freeze-dried tablet (Proxalyoc, Cephalon)
Number of subjects: 16
Study 15847998 — intervention group
Group type: COMPARATOR
Intervention: 20 mg piroxicam capsule (Feldene, Pfizer)
Number of subjects: 16
Study 12655322 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (titrated to 50 mg/day)
Number of subjects: 215
Study 12655322 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene (titrated to 40 mg/day)
Number of subjects: 215
Study 12655322 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215
Study 10914864 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol (0.5 microg) and 1200 mg calcium daily
Number of subjects: 81
Study 10914864 — intervention group
Group type: COMPARATOR
Intervention: Calcium and placebo calcitriol
Number of subjects: 81
Study 10914864 — intervention group
Group type: COMPARATOR
Intervention: Placebo calcitriol and placebo calcium
Number of subjects: 81
Study 8985030 — intervention group
Group type: EXPERIMENTAL
Intervention: Short course radiotherapy (20 Gy in 1 week, daily dose 4 Gy)
Number of subjects: 100
Study 8985030 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (30 Gy in 3 weeks, daily dose 2 Gy)
Number of subjects: 100
Study 1569224 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine digluconate (CHX) used in oral irrigator, 2 x daily for 56 days
Number of subjects: 16
Study 1569224 — intervention group
Group type: COMPARATOR
Intervention: Placebo used in oral irrigator
Number of subjects: 16
Study 1569224 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine digluconate (CHX)
Number of subjects: 16
Study 6141188 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam, 30 mg
Number of subjects: 21
Study 6141188 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam, 0.5 mg
Number of subjects: 21
Study 6141188 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 31411498 — intervention group
Group type: EXPERIMENTAL
Intervention: Gla‐300
Number of subjects: 18
Study 29784145 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyme honey rinses
Number of subjects: 72
Study 29784145 — intervention group
Group type: COMPARATOR
Intervention: Saline rinses
Number of subjects: 72
Study 27043915 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,100 ppm F as NaF
Number of subjects: 21
Study 27043915 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,100 ppm F as SnF2
Number of subjects: 21
Study 27043915 — intervention group
Group type: COMPARATOR
Intervention: 0 ppm F (fluoride-free)
Number of subjects: 21
Study 24361804 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss >2 kg
Number of subjects: 994
Study 24361804 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss >2 kg in LBBB patients
Number of subjects: 994
Study 21543662 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (10, 40, 90, or 120 mg single dose; 40 or 60 mg twice a day for 7 days)
Number of subjects: 49
Study 21543662 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2D6*10/*10 genotype
Number of subjects: 49
Study 21125038 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularisation plus medical therapy
Number of subjects: 806
Study 21125038 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 806
Study 18042520 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased intakes of fruits and stir-fried vegetables (3 servings of stir-fried vegetables and 2 servings of fresh fruits) for 4 weeks
Number of subjects: 34
Study 18042520 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 34
Study 15696181 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine hydrochloride 5 mg tablet
Number of subjects: 36
Study 15696181 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 12225311 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 200 mg/day
Number of subjects: 263
Study 12225311 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263
Study 10730603 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer reminder system (CaseWalker)
Number of subjects: 78
Study 10730603 — intervention group
Group type: COMPARATOR
Intervention: Manual reminder system (paper checklist)
Number of subjects: 78
Study 9201655 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous gammaglobulin (1 gm/kg, max 1 litre of 6 gm/100 ml in 10% w/v maltose solution)
Number of subjects: 71
Study 9201655 — intervention group
Group type: COMPARATOR
Intervention: Dummy solution (10% w/v maltose solution with 1% albumin of equivalent volume)
Number of subjects: 71
Study 1332529 — intervention group
Group type: EXPERIMENTAL
Intervention: S(+)‐ketamine (1 mg/kg BW)
Number of subjects: 10
Study 1332529 — intervention group
Group type: COMPARATOR
Intervention: Racemic ketamine (2 mg/kg BW)
Number of subjects: 10
Study 1332529 — intervention group
Group type: EXPERIMENTAL
Intervention: Both S(+)‐ketamine and racemic ketamine
Number of subjects: 10
Study 1332529 — intervention group
Group type: EXPERIMENTAL
Intervention: S(+)‐ketamine
Number of subjects: 10
Study 3510642 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous pirmenol (50‐100 mg)
Number of subjects: 40
Study 3510642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31382569 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 1118
Study 31382569 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1118
Study 29404796 — intervention group
Group type: EXPERIMENTAL
Intervention: CRRT with a PMMA membrane hemofilter (PMMA group)
Number of subjects: 26
Study 29404796 — intervention group
Group type: COMPARATOR
Intervention: CRRT with a polysulfone membrane hemofilter (PS group)
Number of subjects: 26
Study 29404796 — intervention group
Group type: COMPARATOR
Intervention: NHD group
Number of subjects: 26
Study 26410665 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rating level of perceived exertion during a 12-week cardiac rehabilitation programme.
Number of subjects: 97
Study 26410665 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rating level of perceived exertion with adjustment for rate-reducing medication.
Number of subjects: 97
Study 23679091 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) 0.3 g/kg body mass
Number of subjects: 7
Study 23679091 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride (NaCl) 0.045 g/kg body mass
Number of subjects: 7
Study 23679091 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 7
Study 22500572 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar tissue sealant device plus unipolar cautery
Number of subjects: 60
Study 22500572 — intervention group
Group type: COMPARATOR
Intervention: Unipolar cautery alone
Number of subjects: 60
Study 21526568 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine for 12 weeks
Number of subjects: 1777
Study 21526568 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine group
Number of subjects: 1777
Study 21526568 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 1777
Study 18622963 — intervention group
Group type: EXPERIMENTAL
Intervention: Iontophoretically induced acetylcholine vasodilation (IAV) measured with laser Doppler flux method (LDF)
Number of subjects: 120
Study 18622963 — intervention group
Group type: COMPARATOR
Intervention: Flow mediated dilation (FMD)
Number of subjects: 120
Study 18622963 — intervention group
Group type: EXPERIMENTAL
Intervention: LDF-measured EA
Number of subjects: 120
Study 15886286 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NIT) at a starting dose of 10 microg/min
Number of subjects: 37
Study 15886286 — intervention group
Group type: COMPARATOR
Intervention: Nitroprusside (NIP) at a starting dose of 0.25 microg/kg/min
Number of subjects: 37
Study 15886286 — intervention group
Group type: EXPERIMENTAL
Intervention: Both NIT and NIP
Number of subjects: 37
Study 11840436 — intervention group
Group type: EXPERIMENTAL
Intervention: COBRA therapy (combination of prednisolone, methotrexate, and sulfasalazine)
Number of subjects: 0
Study 11840436 — intervention group
Group type: COMPARATOR
Intervention: SSZ monotherapy
Number of subjects: 0
Study 11840436 — intervention group
Group type: EXPERIMENTAL
Intervention: COBRA therapy
Number of subjects: 0
Study 10636578 — intervention group
Group type: EXPERIMENTAL
Intervention: Full bladder (pre-filled to 60% of maximum capacity)
Number of subjects: 12
Study 10636578 — intervention group
Group type: COMPARATOR
Intervention: Empty bladder
Number of subjects: 12
Study 10636578 — intervention group
Group type: EXPERIMENTAL
Intervention: Full bladder
Number of subjects: 12
Study 7792703 — intervention group
Group type: EXPERIMENTAL
Intervention: No-touch technique protocol
Number of subjects: 0
Study 7792703 — intervention group
Group type: COMPARATOR
Intervention: Surgery without the no-touch technique protocol
Number of subjects: 0
Study 2039637 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 40
Study 2039637 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 40
Study 31609059 — intervention group
Group type: EXPERIMENTAL
Intervention: Major depressive disorder (MDD)‐related genetic risk score (GRSMDD)
Number of subjects: 251125
Study 31609059 — intervention group
Group type: EXPERIMENTAL
Intervention: Carrying 10 additional BMI increasing alleles among depressed individuals
Number of subjects: 251125
Study 31609059 — intervention group
Group type: COMPARATOR
Intervention: Carrying 10 additional BMI increasing alleles among controls
Number of subjects: 251125
Study 31609059 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction with genetic risk score for BMI (GRSBMI)
Number of subjects: 251125
Study 29083444 — intervention group
Group type: EXPERIMENTAL
Intervention: Identification of determinants in Aircraft aging (structural aging)
Number of subjects: 0
Study 29083444 — intervention group
Group type: EXPERIMENTAL
Intervention: Development of P4 Systems medicine inspired new methodologies in predictive maintenance
Number of subjects: 0
Study 26182172 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity grade 2 plus 3 (BMI >35.0)
Number of subjects: 67142
Study 26182172 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI of 35.0 or higher
Number of subjects: 67142
Study 26182172 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity grade 2 plus 3
Number of subjects: 67142
Study 26182172 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline BMI <25.0 with >5% body weight gain
Number of subjects: 67142
Study 26182172 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight change (gain or loss) among overweight or obese women
Number of subjects: 67142
Study 23636283 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium intake > 1200 mg/day
Number of subjects: 331
Study 23636283 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist-to-height ratio > 0.5
Number of subjects: 331
Study 23636283 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 331
Study 21324118 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic electrical therapy for atrial tachycardia and fibrillation (AT/AF)
Number of subjects: 0
Study 21324118 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment of AT/AF (hospitalization for symptoms and in-hospital treatment)
Number of subjects: 0
Study 19689798 — intervention group
Group type: EXPERIMENTAL
Intervention: cis-9, trans-11 CLA
Number of subjects: 34
Study 19689798 — intervention group
Group type: EXPERIMENTAL
Intervention: trans-10,cis-12 CLA
Number of subjects: 34
Study 19689798 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:1 mixture of both isomers
Number of subjects: 34
Study 19689798 — intervention group
Group type: COMPARATOR
Intervention: Reference linoleic acid oil preparation
Number of subjects: 34
Study 17239165 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg clopidogrel loading dose + 325 mg ASA
Number of subjects: 11
Study 17239165 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg clopidogrel loading dose + 325 mg ASA
Number of subjects: 11
Study 17239165 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 platelet concentrate units (equivalent to 40% V-PRP)
Number of subjects: 11
Study 17239165 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 units (50% V-PRP)
Number of subjects: 11
Study 17239165 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 units
Number of subjects: 11
Study 15006921 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF-1 highest tertile
Number of subjects: 493
Study 15006921 — intervention group
Group type: EXPERIMENTAL
Intervention: IGFBP-3 highest tertile
Number of subjects: 493
Study 15006921 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF-1:IGFBP-3 molar ratio highest tertile
Number of subjects: 493
Study 11521985 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NAME 180 microg/kg/h
Number of subjects: 8
Study 11521985 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraduodenal lipid infusion (2 kcal/min)
Number of subjects: 8
Study 11521985 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 8
Study 9972119 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg doxycycline BID (Periostat)
Number of subjects: 38
Study 9972119 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical scaling and root planing (SRP)
Number of subjects: 38
Study 9972119 — intervention group
Group type: EXPERIMENTAL
Intervention: Culture analysis of the 3 most prevalent isolates
Number of subjects: 38
Study 9972119 — intervention group
Group type: EXPERIMENTAL
Intervention: Etest susceptibility patterns
Number of subjects: 38
Study 7804295 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured baseline intervention including clear expectations, social reinforcement, and decelerative procedures.
Number of subjects: 1
Study 7804295 — intervention group
Group type: COMPARATOR
Intervention: Natural baseline with staff reluctance to deliver instructions and corrective feedback.
Number of subjects: 1
Study 7804295 — intervention group
Group type: EXPERIMENTAL
Intervention: Reintroduction of regular staff with instruction and corrective feedback.
Number of subjects: 1
Study 7804295 — intervention group
Group type: EXPERIMENTAL
Intervention: Replication of both baseline conditions six months later.
Number of subjects: 1
Study 3290018 — intervention group
Group type: EXPERIMENTAL
Intervention: sorbinil (aldose reductase inhibitor)
Number of subjects: 39
Study 3290018 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 39
Study 30760195 — intervention group
Group type: EXPERIMENTAL
Intervention: ω-3 fatty acids
Number of subjects: 74
Study 30760195 — intervention group
Group type: EXPERIMENTAL
Intervention: nano-curcumin
Number of subjects: 74